+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Onychomycosis Treatment Market 2023-2027

  • PDF Icon

    Report

  • 161 Pages
  • June 2023
  • Region: Global
  • TechNavio
  • ID: 5847348
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The onychomycosis treatment market is forecasted to grow by USD 1,776.53 mn during 2022-2027, accelerating at a CAGR of 7.44% during the forecast period. The report on the onychomycosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of onychomycosis, increasing awareness of onychomycosis treatment, and the growing aging population.

The onychomycosis treatment market is segmented as below:

By Type

  • Pharmacological
  • Non-pharmacological

By Distribution Channel

  • Offline
  • Online

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing demand for topical treatment for onychomycosis as one of the prime reasons driving the onychomycosis treatment market growth during the next few years. Also, advancements in technology in onychomycosis treatment and increasing adoption of combination therapies for the treatment of onychomycosis will lead to sizable demand in the market.

The report on the onychomycosis treatment market covers the following areas:

  • Onychomycosis treatment market sizing
  • Onychomycosis treatment market forecast
  • Onychomycosis treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading onychomycosis treatment market vendors that include Alembic Pharmaceuticals Ltd., Almirall SA, Astellas Pharma Inc., Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Fotona d.o.o, Galderma SA, GlaxoSmithKline Plc, Kaken Pharmaceutical Co. Ltd., Lupin Ltd., Medimetriks Pharmaceuticals Inc., Moberg Pharma AB, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., and The OTClab B.V.. Also, the onychomycosis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
  • Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global onychomycosis treatment market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global onychomycosis treatment market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
  • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
  • Exhibit 32: Chart on Comparison by Type
  • Exhibit 33: Data Table on Comparison by Type
6.3 Pharmacological - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Pharmacological - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Pharmacological - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Pharmacological - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Pharmacological - Year-over-year growth 2022-2027 (%)
6.4 Non-pharmacological - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Non-pharmacological - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Non-pharmacological - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Non-pharmacological - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Non-pharmacological - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
  • Exhibit 42: Market opportunity by Type ($ million)
  • Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
  • Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
  • Exhibit 46: Chart on Comparison by Distribution Channel
  • Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
  • Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
  • Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
  • Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
  • Exhibit 56: Market opportunity by Distribution Channel ($ million)
  • Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
  • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
  • Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
  • Exhibit 61: Chart on Geographic comparison
  • Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
  • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
  • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
  • Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
  • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
  • Exhibit 99: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
11.4 Industry risks
  • Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
  • Exhibit 105: Vendors covered
12.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
12.3 Almirall SA
  • Exhibit 107: Almirall SA - Overview
  • Exhibit 108: Almirall SA - Product/Service
  • Exhibit 109: Almirall SA - Key news
  • Exhibit 110: Almirall SA - Key offerings
12.4 Astellas Pharma Inc.
  • Exhibit 111: Astellas Pharma Inc. - Overview
  • Exhibit 112: Astellas Pharma Inc. - Product/Service
  • Exhibit 113: Astellas Pharma Inc. - Key news
  • Exhibit 114: Astellas Pharma Inc. - Key offerings
12.5 Bausch Health Co. Inc.
  • Exhibit 115: Bausch Health Co. Inc. - Overview
  • Exhibit 116: Bausch Health Co. Inc. - Business segments
  • Exhibit 117: Bausch Health Co. Inc. - Key news
  • Exhibit 118: Bausch Health Co. Inc. - Key offerings
  • Exhibit 119: Bausch Health Co. Inc. - Segment focus
12.6 Bayer AG
  • Exhibit 120: Bayer AG - Overview
  • Exhibit 121: Bayer AG - Business segments
  • Exhibit 122: Bayer AG - Key news
  • Exhibit 123: Bayer AG - Key offerings
  • Exhibit 124: Bayer AG - Segment focus
12.7 Cipla Ltd.
  • Exhibit 125: Cipla Ltd. - Overview
  • Exhibit 126: Cipla Ltd. - Business segments
  • Exhibit 127: Cipla Ltd. - Key news
  • Exhibit 128: Cipla Ltd. - Key offerings
  • Exhibit 129: Cipla Ltd. - Segment focus
12.8 Fotona d.o.o
  • Exhibit 130: Fotona d.o.o - Overview
  • Exhibit 131: Fotona d.o.o - Product/Service
  • Exhibit 132: Fotona d.o.o - Key offerings
12.9 Galderma SA
  • Exhibit 133: Galderma SA - Overview
  • Exhibit 134: Galderma SA - Product/Service
  • Exhibit 135: Galderma SA - Key news
  • Exhibit 136: Galderma SA - Key offerings
12.10 GlaxoSmithKline Plc
  • Exhibit 137: GlaxoSmithKline Plc - Overview
  • Exhibit 138: GlaxoSmithKline Plc - Business segments
  • Exhibit 139: GlaxoSmithKline Plc - Key news
  • Exhibit 140: GlaxoSmithKline Plc - Key offerings
  • Exhibit 141: GlaxoSmithKline Plc - Segment focus
12.11 Kaken Pharmaceutical Co. Ltd.
  • Exhibit 142: Kaken Pharmaceutical Co. Ltd. - Overview
  • Exhibit 143: Kaken Pharmaceutical Co. Ltd. - Business segments
  • Exhibit 144: Kaken Pharmaceutical Co. Ltd. - Key offerings
  • Exhibit 145: Kaken Pharmaceutical Co. Ltd. - Segment focus
12.12 Medimetriks Pharmaceuticals Inc.
  • Exhibit 146: Medimetriks Pharmaceuticals Inc. - Overview
  • Exhibit 147: Medimetriks Pharmaceuticals Inc. - Product/Service
  • Exhibit 148: Medimetriks Pharmaceuticals Inc. - Key offerings
12.13 Moberg Pharma AB
  • Exhibit 149: Moberg Pharma AB - Overview
  • Exhibit 150: Moberg Pharma AB - Product/Service
  • Exhibit 151: Moberg Pharma AB - Key offerings
12.14 Novartis AG
  • Exhibit 152: Novartis AG - Overview
  • Exhibit 153: Novartis AG - Business segments
  • Exhibit 154: Novartis AG - Key offerings
  • Exhibit 155: Novartis AG - Segment focus
12.15 Pfizer Inc.
  • Exhibit 156: Pfizer Inc. - Overview
  • Exhibit 157: Pfizer Inc. - Product/Service
  • Exhibit 158: Pfizer Inc. - Key news
  • Exhibit 159: Pfizer Inc. - Key offerings
12.16 Sanofi
  • Exhibit 160: Sanofi - Overview
  • Exhibit 161: Sanofi - Business segments
  • Exhibit 162: Sanofi - Key news
  • Exhibit 163: Sanofi - Key offerings
  • Exhibit 164: Sanofi - Segment focus
12.17 The OTClab B.V.
  • Exhibit 165: The OTClab B.V. - Overview
  • Exhibit 166: The OTClab B.V. - Product/Service
  • Exhibit 167: The OTClab B.V. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
  • Exhibit 168: Inclusions checklist
  • Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
  • Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
  • Exhibit 171: Research methodology
  • Exhibit 172: Validation techniques employed for market sizing
  • Exhibit 173: Information sources
13.5 List of abbreviations
  • Exhibit 174: List of abbreviations
Exhibits:
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global onychomycosis treatment market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Pharmacological - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Pharmacological - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Pharmacological - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Pharmacological - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Non-pharmacological - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Non-pharmacological - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Non-pharmacological - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Non-pharmacological - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Distribution Channel
Exhibits 47: Data Table on Comparison by Distribution Channel
Exhibits 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits 56: Market opportunity by Distribution Channel ($ million)
Exhibits 57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ million)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 101: Impact of drivers and challenges in 2022 and 2027
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Almirall SA - Overview
Exhibits 108: Almirall SA - Product/Service
Exhibits 109: Almirall SA - Key news
Exhibits 110: Almirall SA - Key offerings
Exhibits 111: Astellas Pharma Inc. - Overview
Exhibits 112: Astellas Pharma Inc. - Product/Service
Exhibits 113: Astellas Pharma Inc. - Key news
Exhibits 114: Astellas Pharma Inc. - Key offerings
Exhibits 115: Bausch Health Co. Inc. - Overview
Exhibits 116: Bausch Health Co. Inc. - Business segments
Exhibits 117: Bausch Health Co. Inc. - Key news
Exhibits 118: Bausch Health Co. Inc. - Key offerings
Exhibits 119: Bausch Health Co. Inc. - Segment focus
Exhibits 120: Bayer AG - Overview
Exhibits 121: Bayer AG - Business segments
Exhibits 122: Bayer AG - Key news
Exhibits 123: Bayer AG - Key offerings
Exhibits 124: Bayer AG - Segment focus
Exhibits 125: Cipla Ltd. - Overview
Exhibits 126: Cipla Ltd. - Business segments
Exhibits 127: Cipla Ltd. - Key news
Exhibits 128: Cipla Ltd. - Key offerings
Exhibits 129: Cipla Ltd. - Segment focus
Exhibits 130: Fotona d.o.o - Overview
Exhibits 131: Fotona d.o.o - Product/Service
Exhibits 132: Fotona d.o.o - Key offerings
Exhibits 133: Galderma SA - Overview
Exhibits 134: Galderma SA - Product/Service
Exhibits 135: Galderma SA - Key news
Exhibits 136: Galderma SA - Key offerings
Exhibits 137: GlaxoSmithKline Plc - Overview
Exhibits 138: GlaxoSmithKline Plc - Business segments
Exhibits 139: GlaxoSmithKline Plc - Key news
Exhibits 140: GlaxoSmithKline Plc - Key offerings
Exhibits 141: GlaxoSmithKline Plc - Segment focus
Exhibits 142: Kaken Pharmaceutical Co. Ltd. - Overview
Exhibits 143: Kaken Pharmaceutical Co. Ltd. - Business segments
Exhibits 144: Kaken Pharmaceutical Co. Ltd. - Key offerings
Exhibits 145: Kaken Pharmaceutical Co. Ltd. - Segment focus
Exhibits 146: Medimetriks Pharmaceuticals Inc. - Overview
Exhibits 147: Medimetriks Pharmaceuticals Inc. - Product/Service
Exhibits 148: Medimetriks Pharmaceuticals Inc. - Key offerings
Exhibits 149: Moberg Pharma AB - Overview
Exhibits 150: Moberg Pharma AB - Product/Service
Exhibits 151: Moberg Pharma AB - Key offerings
Exhibits 152: Novartis AG - Overview
Exhibits 153: Novartis AG - Business segments
Exhibits 154: Novartis AG - Key offerings
Exhibits 155: Novartis AG - Segment focus
Exhibits 156: Pfizer Inc. - Overview
Exhibits 157: Pfizer Inc. - Product/Service
Exhibits 158: Pfizer Inc. - Key news
Exhibits 159: Pfizer Inc. - Key offerings
Exhibits 160: Sanofi - Overview
Exhibits 161: Sanofi - Business segments
Exhibits 162: Sanofi - Key news
Exhibits 163: Sanofi - Key offerings
Exhibits 164: Sanofi - Segment focus
Exhibits 165: The OTClab B.V. - Overview
Exhibits 166: The OTClab B.V. - Product/Service
Exhibits 167: The OTClab B.V. - Key offerings
Exhibits 168: Inclusions checklist
Exhibits 169: Exclusions checklist
Exhibits 170: Currency conversion rates for US$
Exhibits 171: Research methodology
Exhibits 172: Validation techniques employed for market sizing
Exhibits 173: Information sources
Exhibits 174: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global onychomycosis treatment market: Alembic Pharmaceuticals Ltd., Almirall SA, Astellas Pharma Inc., Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Fotona d.o.o, Galderma SA, GlaxoSmithKline Plc, Kaken Pharmaceutical Co. Ltd., Lupin Ltd., Medimetriks Pharmaceuticals Inc., Moberg Pharma AB, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., and The OTClab B.V.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing demand for topical treatment for onychomycosis.'

According to the report, one of the major drivers for this market is the increasing prevalence of onychomycosis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alembic Pharmaceuticals Ltd.
  • Almirall SA
  • Astellas Pharma Inc.
  • Bausch Health Co. Inc.
  • Bayer AG
  • Cipla Ltd.
  • Dr Reddys Laboratories Ltd.
  • Fotona d.o.o
  • Galderma SA
  • GlaxoSmithKline Plc
  • Kaken Pharmaceutical Co. Ltd.
  • Lupin Ltd.
  • Medimetriks Pharmaceuticals Inc.
  • Moberg Pharma AB
  • Novartis AG
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • The OTClab B.V.

Related Topics

Related Reports

Global Gonorrhea Therapeutics Market 2023-2027 - Product Image

Global Gonorrhea Therapeutics Market 2023-2027

  • Report
  • 162 Pages
  • Global
From
Onychomycosis Global Market Report 2024 - Product Image

Onychomycosis Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 126 Pages
  • Global
From
Global Onychomycosis Treatment Market by Treatment (Drugs, Laser Therapy, Photodynamic Therapy), Type (Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis) - Forecast 2024-2030 - Product Image

Global Onychomycosis Treatment Market by Treatment (Drugs, Laser Therapy, Photodynamic Therapy), Type (Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis) - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Onychomycosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Onychomycosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.